NRAS mutation status is an independent prognostic factor in metastatic melanoma

John A. Jakob, Roland L. Bassett, Chaan S. Ng, Jonathan L. Curry, Richard W. Joseph, Gladys C. Alvarado, Michelle L. Rohlfs, Jessie Richard, Jeffrey E. Gershenwald, Kevin B. Kim, Alexander J. Lazar, Patrick Hwu, Michael A. Davies

Research output: Contribution to journalArticlepeer-review

440 Scopus citations

Fingerprint

Dive into the research topics of 'NRAS mutation status is an independent prognostic factor in metastatic melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences